One of the company’s original technologies that successfully purified the Fermented Horse Milk exosome (namely BNEV). BNEV possesses a very high anti-inflammatory effect, especially can inhibit the main cause of atopic dermatitis TARC, which resulted in no longer need to rely on topical steroids, immunosuppressants. Therefore, BNEV has become very popular in medical institutions and pharmaceutical companies. In collaboration with Professor Ochiya Takahiro of of the Tokyo Medical University, we successfully apply and obtain the patent for Fermented Horse Milk exosomes. It has been extremely important and would become a life saver for patients suffering from dermatitis such as eczema.
